Delivery Order SPE2DB22D3102-SPE2DB25FL2UX
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,037.39 to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units). This firm fixed-price, competitively awarded contract was issued on August 13, 2025, with an ultimate completion date of August 14, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was used for this procurement. This delivery order represents...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,640.50 to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Progesterone 200 mg capsules (100 count). This is a firm fixed-price delivery order with no set-aside designation, executed through competitive procedures. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and will perform this delivery from its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Progesterone 200 mg capsules (100 count) with a ceiling value of $6,136.78. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of September 9, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units) on September 12, 2025, with a contract ceiling value of $3,769.60 and an ultimate completion date of September 15, 2025. This competitively awarded, non-set-aside delivery order employs firm fixed pricing and represents a pharmaceutical supply transaction to support federal medical procurement needs. The work will be performed at...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units) under a firm fixed-price contract valued at $32,928.71. The award, effective August 5, 2025, with an ultimate completion date of August 6, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Progesterone 100 mg capsules (100-count units) valued at $1,083.44. This competitively awarded, firm fixed-price delivery order was established on September 11, 2025, with an ultimate completion date of September 12, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $7,553.65 firm fixed price delivery order to AmerisourceBergen Drug Corp for Progesterone 200 mg capsules (100 count) on September 8, 2025, with an ultimate completion date of September 9, 2025. The award was made through open competition with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a contract value of $2,651.34. This is a firm fixed-price delivery order with an ultimate completion date of August 7, 2025, and represents work to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation applied. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units) under a firm fixed price contract valued at $11,828.08. The award, issued on September 9, 2025, with an ultimate completion date of September 10, 2025, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania, leveraging its...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units) with a ceiling value of $3,109.36. This competitively awarded, firm fixed-price delivery order was issued on August 18, 2025, with an ultimate completion date of August 19, 2025. The contract contains no set-aside designation, and performance will take place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This...
- SPE2DB22D3102Indefinite Delivery Contract
- SPE2DB22D3102-SPE2DB25FL2UXDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,692.06 to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units). This competitive contract, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA 19428. This delivery order is a child contract under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs and the Defense Health Agency. AmerisourceBergen Drug Corp's federal contract portfolio demonstrates its capacity to fulfill critical pharmaceutical procurement requirements across multiple therapeutic domains through competitive federal procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.7k | 9/3/25 |